This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Offman, J. Articles by Karran, P. Search for Related Content PubMed PubMed Citation Articles by Offman, J. Articles by Karran, P.

---

Cancer Genes and Genomics

Repeated Sequences in CASPASE-5 and FANCD2 but not NF1 Are Targets for Mutation in Microsatellite-Unstable Acute Leukemia/Myelodysplastic Syndrome

¹ Cancer Research UK London Research Institute, Mammalian DNA Repair Laboratory, Clare Hall Laboratories, South Mimms, Herts, United Kingdom; ² Istituto Superiore di Sanitá; ³ Department of Hematology, Catholic University, Rome, Italy; and ⁴ Harefield Hospital, Harefield, Middlesex, United Kingdom

Requests for reprints: Peter Karran, Cancer Research UK London Research Institute, Mammalian DNA Repair Laboratory, Clare Hall Laboratories, South Mimms, Herts, United Kingdom EN6 3LD. Phone: 44-207-269-3870; Fax: 44-207-269-3812. E-mail: peter.karran{at}cancer.org.uk

Microsatellite instability (MSI) in tumors is diagnostic for inactive DNA mismatch repair. It is widespread among some tumor types, such as colorectal or endometrial carcinoma, but is rarely found in leukemia. Therapy-related acute myeloid leukemia/myelodysplastic syndrome (tAML/MDS) is an exception, and MSI is frequent in tAML/MDS following cancer chemotherapy or organ transplantation. The development of MSI⁺ tumors is associated with an accumulation of insertion/deletion mutations in repetitive sequences. These events can cause inactivating frameshifts or loss of expression of key growth control proteins. We examined established MSI⁺ cell lines and tAML/MDS cases for frameshift-like mutations of repetitive sequences in several genes that have known, or suspected, relevance to leukemia. CASPASE-5, an acknowledged frameshift target in MSI⁺ gastrointestinal tract tumors, was frequently mutated in MSI⁺ cell lines (67%) and in tAML/MDS (29%). Frameshift-like mutations were also observed in the NF1 and FANCD2 genes that are associated with genetic conditions conferring a predisposition to leukemia. Both genes were frequent targets for mutation in MSI⁺ cell lines and colorectal carcinomas. FANCD2 mutations were also common in MSI⁺ tAML/MDS, although NF1 mutations were not observed. A novel FANCD2 polymorphism was also identified.

This article has been cited by other articles:

				G. Mao, X. Pan, and L. Gu Evidence That a Mutation in the MLH1 3'-Untranslated Region Confers a Mutator Phenotype and Mismatch Repair Deficiency in Patients with Relapsed Leukemia J. Biol. Chem., February 8, 2008; 283(6): 3211 - 3216. [Abstract] [Full Text] [PDF]

				G. Leone, L. Pagano, D. Ben-Yehuda, and M. T. Voso Therapy-related leukemia and myelodysplasia: susceptibility and incidence Haematologica, October 1, 2007; 92(10): 1389 - 1398. [Abstract] [Full Text] [PDF]